← Back to Analyst Consensus 
HCSG Buy
HEALTHCARE SERVICES GROUP INC
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 8, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Aug 19, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Jul 8, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 23, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 23, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Apr 23, 2026 | Benchmark | maintain | Buy → Buy | — | 54% |
| Apr 23, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Mar 3, 2026 | RBC Capital | initiate | — → Sector Perform | — | 55% |
| Nov 13, 2025 | BMO Capital | initiate | — → Market Perform | $20 | 53% |
| Oct 28, 2025 | UBS | maintain | Buy → Buy | $22 | 54% |
| Oct 23, 2025 | Benchmark | maintain | Buy → Buy | $24 | 54% |
| Jul 29, 2025 | Macquarie | upgrade | Neutral → Outperform | $16 | 56% |
| Jul 24, 2025 | Benchmark | maintain | Buy → Buy | $19 | 54% |
| Jul 24, 2025 | Baird | maintain | Neutral → Neutral | $15 | 55% |
| Apr 28, 2025 | Macquarie | maintain | Neutral → Neutral | $15 | 56% |
| Apr 24, 2025 | Baird | maintain | Neutral → Neutral | $13 | 55% |
| Apr 24, 2025 | UBS | upgrade | Neutral → Buy | $15 | 54% |
| Dec 19, 2024 | Benchmark | reiterate | Buy → Buy | $17 | 54% |
| Dec 16, 2024 | Macquarie | initiate | — → Neutral | $13 | 56% |
| Oct 24, 2024 | Benchmark | reiterate | Buy → Buy | $17 | 54% |
| Oct 24, 2024 | Baird | maintain | Neutral → Neutral | $12 | 55% |
| Jul 25, 2024 | Benchmark | reiterate | Buy → Buy | $17 | 54% |
| Jul 25, 2024 | RBC Capital | maintain | Outperform → Outperform | $14 | 55% |
| Jul 25, 2024 | Baird | maintain | Neutral → Neutral | $14 | 55% |
| Feb 15, 2024 | Benchmark | maintain | Buy → Buy | $17 | 54% |
| Feb 15, 2024 | UBS | maintain | Neutral → Neutral | $13 | 54% |
| Feb 15, 2024 | Baird | maintain | Neutral → Neutral | $13 | 55% |
| Feb 15, 2024 | RBC Capital | maintain | Outperform → Outperform | $15 | 55% |
| Dec 22, 2023 | Benchmark | reiterate | Buy → Buy | $16 | 54% |
| Nov 30, 2023 | UBS | initiate | — → Neutral | $11 | 54% |
| Oct 26, 2023 | RBC Capital | maintain | Outperform → Outperform | $14 | 55% |
| Oct 26, 2023 | Benchmark | maintain | Buy → Buy | $16 | 54% |
| Aug 31, 2023 | Benchmark | reiterate | Buy → Buy | $18 | 54% |
| Aug 1, 2023 | RBC Capital | reiterate | Outperform → Outperform | $16 | 55% |
| Jul 27, 2023 | RBC Capital | maintain | Outperform → Outperform | $16 | 55% |
| Apr 28, 2023 | Credit Suisse | maintain | — → Neutral | $17 | — |
| Apr 27, 2023 | RBC Capital | reiterate | — → Outperform | $17 | 55% |
| Mar 24, 2023 | Jefferies | upgrade | Underperform → Hold | $14 | 52% |
| Feb 21, 2023 | Benchmark | reiterate | — → Buy | $18 | 54% |
| Feb 17, 2023 | Credit Suisse | maintain | — → Neutral | $14 | — |
| Feb 17, 2023 | RBC Capital | upgrade | Sector Perform → Outperform | $17 | 55% |
| Feb 13, 2023 | Benchmark | reiterate | — → Buy | $18 | 54% |
| Oct 20, 2022 | Benchmark | upgrade | Hold → Buy | $18 | 54% |
| Oct 20, 2022 | Credit Suisse | maintain | — → Neutral | $12 | — |
| Oct 20, 2022 | RBC Capital | maintain | — → Sector Perform | $14 | 55% |
| Apr 21, 2022 | Credit Suisse | maintain | — → Neutral | $18 | — |
| Apr 21, 2022 | RBC Capital | maintain | — → Sector Perform | $20 | 55% |
| Feb 10, 2022 | Jefferies | downgrade | Hold → Underperform | $13.5 | 52% |
| Oct 22, 2021 | Credit Suisse | maintain | — → Neutral | $22 | — |
| Oct 21, 2021 | RBC Capital | maintain | — → Sector Perform | $20 | 55% |
Price Target Trend
Apr 2, 2026 Oct 25, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days